Client Result

MRD Monitoring Market Assessment and Strategy

Project Overview

A diagnostics player wanted to determine which indications and use cases to target and develop a product road map for its planned MRD offering

DeciBio Approach

Primary Research

  • Interviewed 30 U.S.-based oncologists covering 10+ indications to identify and prioritize use cases and indications for future business development
  • Interviews spanned a representative mix of generalists and specialists, and clinicians from both the community and academic settings

Secondary Research

  • Identified and characterized MRD trials
  • Reviewed MRD development pipelines of key market players
  • Benchmarked MRD assay specifications against each other and stakeholder perspectives of performance requirements
At a glance
60
Potential Use Cases Assessed
12
Indications Investigated
30
Interviews
Outcomes

DeciBio presented to the client a deliverable discussing discrete use cases of the highest interest to the client team, and deep dives of each.  The report included an assessment of:

  • U.S. ctDNA MRD and monitoring market opportunity
  • Top use cases prioritized by clinical need, competitive opportunity, and alignment with client technology and capabilities
  • Customer feeback on pain points, unmet needs, and opportunities for differentiation in the MRD space

The client leveraged this output to prioritize investments into 3 specific indication-application areas for the development of its planned MRD assay.

Timeline

7 weeks

Geographic Scope

U.S.

Industry

Clinical Diagnostics

capabilities

Biomarker and Diagnostic Strategy

Go-to-Market Strategy

Competitive Analysis

Voice-Of-Customer Research

Related Client Results

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.